title: Should-alpha-interferon be included as standard treatment in multiple myeloma?
authors.affiliation: 1st Department of Medicine and Oncology, Wilhelminenspital, Vienna, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Ludwig
authors.forename: E
authors.initials: E
authors.lastname: Fritz
authors.forename: G B
authors.initials: GB
authors.lastname: Zulian
authors.forename: G P
authors.initials: GP
authors.lastname: Browman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000628:therapy*; D017060:Patient Satisfaction; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha